**Summary of Venture Life Group PLC Interim Results (30 September 2025):**
**Overview**
Venture Life Group PLC (AIMVLG), a leader in proactive healthy longevity and consumer healthcare, announced its unaudited interim results for the period ended 30 June 2025. The Group reported robust revenue growth from continuing operations, driven by strategic marketing investments, and outlined plans for a share buyback program.
**Financial Highlights – Continuing Operations:**
**Revenue Growth** Increased by 43.1% to £15.4 million (2024: £10.8 million), with 12.4% growth on a proforma basis.
**Gross Profit** Rose by 49.9% to £6.6 million, with a gross margin improvement to 43.1%.
**Adjusted EBITDA** Increased by 32.6% to £1.8 million, though the margin declined to 11.6%.
**Operating Loss** Widened to £1.4 million (2024: £0.4 million), while adjusted profit before tax rose to £0.8 million.
**Cash Position** Free cash flow decreased to £1.5 million, but the Group achieved a net cash position of £34.1 million post-period.
**Operational Highlights**
**Acquisition of Health and Her Limited (H&H):** Completed in November 2024, contributing £4.1 million in revenues and achieving 38% proforma growth.
**Divestment of CDMO and Non-Core Products:** Sold to BioDue S.p.A for €62 million in July 2025, with proceeds used to repay debt and strengthen the balance sheet.
**Share Buyback Program** Intention to repurchase up to 12,805,231 ordinary shares announced.
**Strategic Focus**
**Brand-Centric Approach** Transitioning to a higher-margin, brand-focused consumer healthcare business, emphasizing organic growth and selective acquisitions.
**Geographic Focus** Concentrating on the UK, EU, and US markets.
**Digital Transformation** Investing in digital capabilities, AI, and data-driven insights to enhance customer engagement and operational efficiency.
**Post-Period Developments**
**Net Cash Position** £34.1 million as of 30 September 2025, with access to a £30 million revolving credit facility.
**Management Strengthening** Proposed appointments of Kate Bache (Chief Marketing and Innovation Officer) and Peter Jackson (Chief Digital and Technology Officer).
**M&A Opportunities** Actively pursuing potential mergers and acquisitions to complement existing brands.
**CEO Commentary**
Jerry Randall highlighted the Groups transformational progress, including streamlining operations, generating significant funding, and focusing on organic and acquired growth. He emphasized the dual-track strategy of driving organic growth through omnichannel brands and acquiring complementary assets, supported by digital and AI capabilities.
**Conclusion**
Venture Life Group is repositioning itself as a high-margin, brand-focused consumer healthcare company, with a strong financial position and strategic initiatives aimed at sustainable growth. The share buyback program underscores confidence in the Groups fundamentals and growth potential.